| Date | Time | Source | Headline | Symbol | Company |
| 07/17/2024 | 5:00PM | iHub Newswire | FeaturedNightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com | | |
| 01/30/2009 | 5:10PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/29/2009 | 4:35PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/29/2009 | 12:34PM | PR Newswire (US) | Amylin Pharmaceuticals Comments on Shareholder 13-D Filing | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/29/2009 | 10:13AM | Marketwired | BenchmarkJournal.com (Complimentary) Analyst Review for and AMZN, AMLN, FLEX and ANPI | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/29/2009 | 6:01AM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/27/2009 | 4:12PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/27/2009 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals Reports 2008 Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/26/2009 | 4:30PM | PR Newswire (US) | Amylin Pharmaceuticals Appoints Vincent Mihalik Senior Vice President, Sales and Marketing and Chief Commercial Officer | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/21/2009 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Year-End Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/15/2009 | 5:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/15/2009 | 5:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/15/2009 | 5:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/15/2009 | 5:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/15/2009 | 5:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/15/2009 | 5:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/15/2009 | 5:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/12/2009 | 2:11PM | Dow Jones News | Amylin Sees Byetta Label, Monotherapy Decision In 1Q | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 01/12/2009 | 1:15PM | PR Newswire (US) | Amylin Pharmaceuticals Highlights 2009 Value Creation Opportunities | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/06/2009 | 4:58PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/15/2008 | 10:12AM | Marketwired | BridgewaterEquity.com Free Fundamental Sector & Market Research on GLBL, INTU, ZION and AMLN | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/11/2008 | 4:11PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/11/2008 | 6:30AM | PR Newswire (US) | Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/08/2008 | 4:16PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/08/2008 | 8:00AM | PR Newswire (US) | Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/05/2008 | 10:15AM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/13/2008 | 5:00PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/10/2008 | 5:16PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/10/2008 | 5:15PM | PR Newswire (US) | Amylin Pharmaceuticals Announces Strategic Restructuring and Workforce Reduction | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/07/2008 | 2:43PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |